LBEL
- Product NDC
- 13537-027
- 11-digit product format
- 135370027
- Labeler code
- 13537
- Product ID
- 13537-027_dd5be4e2-fa42-4add-bdb3-a7e27bdf2eb1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide
- Dosage form
- LOTION
- Route
- TOPICAL
- Labeler
- Ventura Corporation Ltd.
- Application
- part352
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Marketing start
- 2011-08-10
- Marketing end
- 0000-00-00
- Substance
- ENSULIZOLE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE
- Active strength
- 0 g/mL; g/mL; g/mL; g/mL; g/mL
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13537-027-01 | 2025-02-20 | C162847 | 48780-1 | 960f7f55-d940-8e05-e053-dbdaa90a074a | bb188f57-a53b-4cde-9abb-c97c576596e8 |
| 13537-027-03 | 2025-02-20 | C162847 | 48780-1 | 960f7f55-d940-8e05-e053-dbdaa90a074a | bb188f57-a53b-4cde-9abb-c97c576596e8 |
| 13537-027-05 | 2025-02-20 | C162847 | 48780-1 | 960f7f55-d940-8e05-e053-dbdaa90a074a | bb188f57-a53b-4cde-9abb-c97c576596e8 |
| 13537-027-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d940-8e05-e053-dbdaa90a074a | bb188f57-a53b-4cde-9abb-c97c576596e8 |
| 13537-027-03 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d940-8e05-e053-dbdaa90a074a | bb188f57-a53b-4cde-9abb-c97c576596e8 |
| 13537-027-05 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d940-8e05-e053-dbdaa90a074a | bb188f57-a53b-4cde-9abb-c97c576596e8 |